Recombinant newcastle disease virus capsids displaying enterovirus 71 VP1 fragment induce a strong immune response in rabbits

Journal of Medical Virology

Volumn 78, Issue 8, 2006, Pages 1096-1104

  Sivasamugham, Lalita Ambigai ^a   Cardosa, Mary Jane ^b   Tan, Wen Siang ^a   Yusoff, Khatijah ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b UNIVERSITI MALAYSIA SARAWAK   (Malaysia)

Author keywords

Enterovirus 71; Immunological reagents; Recombinant NP proteins; VP1

Indexed keywords

AMINO ACID; NUCLEOCAPSID PROTEIN; PROTEIN VP1; PROTEIN VP1[1-100]; REAGENT; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; COXSACKIE VIRUS A; COXSACKIE VIRUS A16; ENTEROVIRUS 71; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOFLUORESCENCE TEST; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; RABBIT; VIRUS CAPSID; VIRUS RECOMBINANT; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, VIRAL; CAPSID; CAPSID PROTEINS; DNA, VIRAL; ENTEROVIRUS; FEMALE; GENE EXPRESSION REGULATION, VIRAL; NEWCASTLE DISEASE VIRUS; RABBITS;

COXSACKIEVIRUS; ESCHERICHIA COLI; HUMAN ENTEROVIRUS 71; MIRIDAE; NEWCASTLE DISEASE VIRUS; ORYCTOLAGUS CUNICULUS;

EID: 33745726965     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20668     Document Type: Article

References (38)

1. AbuBakar S, Chee HY, Al-Kobaisi MF, Xiaoshan J, Chua KB, Lain SK. 1999. Identification of enterovirus 71 isolates from an outbreak of hand, foot and mouth disease (HFMD) with fatal cases of encephalomyelitis in Malaysia. Virus Res 61:1-9.
2. Adams SE, Dawaon KM, Gull K, Kingsman SM, Kingsman AJ. 1987. The expression of hybrid HIV:Ty virus-like particles in yeast. Nature 329:68-70.
3. Brown BA, Pallansch MA. 1995. Complote nucleotido sequence of enterovirus 71 is distinct from poliovirus. Virus Res 39:195-205.
4. Brunn AV, Brand M, Reichhuber C, Morys-Wortman C, Deinhardt P. Schodel F. 1993. Principal neutralizing domain of HIV-1 is highly immunogcnic when expressed on the surface of Hepatitis B core particles. Vaccine 11:817-824.
5. Cardosa MJ, Krishnan S, Tio PH, Perera D, Wong SC. 1999. Isolation of subgenus B adenovirus during a fatal outbreak of enterovirus 71-associated hand, foot and mouth disease in Sibu, Sarawak. Lancet 354:987-991.
6. Caro V, Guilot S, Delpeyroux F, Crainic R. 2001. Molecular strategy for 'serotyping' of human enteroviruses. J Gen Virol 82:79-91.
7. Chumakov M, Voroshilova M, Shindarov L, Lavrova I, Gracheva L, Koroleva G. 1979. Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Arch Virol 60:329-340.
8. Coligan JE, Dunn BM, Ploegh HL, Speicheir DW, Wingfield PT. 2000. Current protocols in protein science. New York: John Wiley and Sons, Inc pp. 5.2.10.
9. Garcea RL, Gissmann L. 2004. Virus-like particles as vaccines and vessels for the delivery of small molecules. Curr Opin Biotechnol 15:513-517.
10. Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, Tsai SF, Wang JR, Shih SR. 1999. An epidemic of enterovirus 71 infection in Taiwan. N Engl J Med 341:929-935.
11. Hovi T, Roivainen M. 1993. Peptide antisera targeted to a conserved sequence in poliovirus capsid VP1 cross-react widely with members of the genus Enterovirus. J Clin Microbiol 31:1083-1087.
12. Kho CL, Tan WS, Yusoff K. 2001. Production of the nucleocapsid protein of newcastle disease virus in Escherichia coli and its assembly into ring- and nucleocapsid-like particles. J Microbiol 39:293-299.
13. Kho CL, Tan WS, Tey BT, Yusoff K. 2003. NDV nucleocapsid: Self assembly and length determination domains. J Gen Virol 84:2163-2168.
14. Koths K. 1995. Recombinant proteins for medical use: The attractions and challenges. Curr Opin Biotechnol 6:681-687.
15. Libon C, Corvaia N, Haeuw JT, Nguyen TN, Stahl S, Bonnefoy JT, Andreoni C. 1999. The serum albumin-binding region of streptococcal protein G (BB) potentiates the immunogenicity of the G130-230 RSV-A protein. Vaccine 17:406-414.
16. Lin YC, Wu CN, Shih SR, Ho MS. 2002. Characterisation of a Vero cell-adapted virulent strain of enterovirus 71 suitable for use as vaccine candidate. Vaccine 20:2485-2493.
17. Makrides SC. 1996. Strategies for achieving high-level expression of genes in Escherichia coli. Microbiol Rev 60:512-538.
18. McMinn P. 2002. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 26:91-107.
19. Mikhailov M, Monastyrskaya K, Bakker T, Roy P. 1996. A new form of particulate single and multiple immunogen delivery system based on recombinant bluetongue virus-derived tubules. Virol 217:323-331.
20. Miyamura K, Kajigaya S, Monomeda M, Smith-Gill SJ, Young NS. 1994. Parvovirus particles as platforms for protein presentation. Proc Natl Acad Sci USA. 91:8507-8511.
21. Murray K, Shiau AL. 1999. The core antigen of hepatitis B virus as a carrier for immunogenic peptides. Biol Chem 380:277-283.
22. Nagy G, Takatsy S, Kukan E, Mihaly I, Domok I. 1982. Virological diagnosis of enterovirus type 71 infections: Experiences gained during an epidemic of acute CNS diseases in Hungary in 1978. Arch Virol 71:217-227.
23. Oberste MS, Maher K, Kilpatrick DR, Pallansch MA. 1999. Molecular evolution of the human enteroviruses: Correlation of serotype with VP1 sequence and application to picornavirus classification. J Virol 73:1941-1948.
24. Pumpens P, Grens E. 2001. HBV core particles as a carrier for B cell/T cell epitopes. Intervirol 44:98-114.
25. Pushko P, Kozlovskaya T, Sominskaya I, Brede A, Stankevica E, Ose V, Pumpens P, Grens E. 1993. Analysis of RNA phage of coat protein assembly by insertion, deletion and substitution mutagenesis. Protein Eng 6:883-891.
26. Rabu A, Tan WS, Kho CL, Omar AR, Yusoff K. 2002. Chimeric newcastle disease virus nucleocapsid with parts of viral haemagglutinin-neuraminidase and fusion proteins. Acta Virol 46:211-217.
27. Roivainen M, Piirainen L, Rysa T, Narvanen A, Hovi T. 1993. An immunodominant N-Terminal region of VP1 protein of poliovirion that is buried in crystal structure can be exposed in solution. Virol 195:762-765.
28. Saini M, Vrati S. 2003. A Japanese encephalitis virus peptide present on Johnson grass mosaic virus-like particles induces virus-neutralizing antibodies and protects mice against lethal challenge. J Virol 77:3487-3494.
29. Samuda GM, Chang WK, Yeung CY, Tang PS. 1987. Monoplegia caused by enterovirus 71: An outbreak in Hong Kong. Pead Infect Dis J 6:206-208.
30. Schmidt NJ, Lennette EH, Ho HH. 1974. An apparently new enterovirus isolated from patients with disease of central nervous system. J Infect Dis 129:304-309.
31. Sedlik C, Saron MF, Sarraseca J, Casai I, Leclerc C. 1997. Recombinant parvovirus-like particles as an antigen carrier: A novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells. Proc Natl Acad Sci USA 94:7503-7508.
32. Shih RS, Li YS, Chiou CC, Suen PC, Lin TZ, Chang LY, Huang YC, Tsao KC, King HC, Wu TZ, Chang ER. 2000. Expression of capsid protein VP1 for use as antigen for the diagnosis of enterovirus 71 infection. J Med Virol 61:228-234.
33. Sjolander A, Stahl S, Perlman P. 1993. Bacterial expression systems based on protein A and protein G designed for the production of immunogens: Applications to Plasmodium falciparum malaria antigens. ImmunoMethods 2:79-92.
34. Sjolander A, Nygren PA, Stahl S, Berzins K, Uhlen M, Perlmann P, Andersson R. 1997. The serum albumin-binding of streptococcal protein G: A bacterial fusion partner with carrier-related properties. J Immunol Methods. 201:115-123.
35. Ulrich R, Nassal M, Meisel H, Kruger DH. 1998. Core particles of hepatitis B virus as a carrier for foreign epitopes. Adv Virus Res 50:141-182.
36. Voronkova T, Grosch A, Kazaks A, Ose V, Skastrina D, Sasnauskas K, Jandrig B, Arnold W, Scherneck S, Pumpens P, Ulrich R. 2002. Chimeric bacteriophage fr virus-like particles harboring the immunodominant C-terminal region of hamster polyomavirus VP1 induce a strong VP1-specific antibody response in rabbits and mice. Viral Immunol. 15:627-644.
37. Wu CN, Lin YC, Fann C, Liao NS, Shih SR, Ho MS. 2002. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine. 20:895-904.
38. Zaoutis T, Klein JD. 1998. Enterovirus infections. Pediat Rev 19:183-191.